Anastrozole
Brand name: Anastrozole
Rank #447 of 500 drugs by total cost
$17.4M
Total Cost
626,025
Total Claims
$17.4M
Total Cost
9,765
Prescribers
$28
Cost per Claim
167,381
Beneficiaries
1,447,920
30-Day Fills
$1,784
Avg Cost/Provider
64
Avg Claims/Provider
About Anastrozole
Anastrozole (sold as Anastrozole) was prescribed 626,025 times by 9,765 Medicare Part D providers in 2023, costing the program $17.4M. At $28 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 444 | Cladribine (Mavenclad) | $17.5M | 228 |
| 445 | Enalapril Maleate (Enalapril Maleate) | $17.5M | 673,317 |
| 446 | Vismodegib (Erivedge) | $17.4M | 1,317 |
| 447 | Anastrozole (Anastrozole) | $17.4M | 626,025 |
| 448 | Naproxen (Naproxen) | $17.4M | 903,928 |
| 449 | Vedolizumab (Entyvio) | $17.4M | 2,034 |
| 450 | Abatacept/Maltose (Orencia) | $17.2M | 3,809 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology